yemuoside YM(10): from Stauntonia chinensis Decne; structure given in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Stauntonia | genus | [no description available] | Lardizabalaceae | [no description available] |
Stauntonia chinensis | species | [no description available] | Lardizabalaceae | [no description available] |
ID Source | ID |
---|---|
PubMed CID | 195123 |
CHEMBL ID | 3890430 |
SCHEMBL ID | 17187835 |
MeSH ID | M0172763 |
Synonym |
---|
yemuoside ym(10) |
ciwujianoside-b |
28-o-rhamnopyranosyl-(1-4)-glucopyranosyl-(1-6)-glucopyranosyl 3-o-rhamnosyl-(1-2)-arabinopyranosyl-30-norolean-12,20(29)-dien-28-oic acid |
30-noroleana-12,20(29)-dien-28-oic acid, 3-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl)oxy)-, o-6-deoxy-alpha-l-mannopyranosyl-(1-4)-o-beta-d-glucopyranosyl-(1-6)-beta-d-glucopyranosyl ester, (3beta)- |
yemuoside ym10 |
acanthopanax senticosides b |
Q-100073 |
SCHEMBL17187835 |
bdbm50253018 |
yemuoside ym |
CHEMBL3890430 , |
HY-N0307 |
CS-0008805 |
ciwujianoside b; acanthopanax senticosides b |
MS-32037 |
AKOS040753101 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 (µMol) | 97.3000 | 0.0013 | 2.8138 | 9.8200 | AID1453375 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
xanthine dehydrogenase activity | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
xanthine oxidase activity | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
iron ion binding | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
protein binding | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
protein homodimerization activity | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
molybdopterin cofactor binding | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
flavin adenine dinucleotide binding | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
2 iron, 2 sulfur cluster binding | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
hypoxanthine dehydrogenase activity | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
hypoxanthine oxidase activity | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
FAD binding | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
cytosol | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
extracellular space | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
peroxisome | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
cytosol | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
sarcoplasmic reticulum | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
extracellular space | Xanthine dehydrogenase/oxidase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1323390 | Inhibition of amyloid beta (25 to 35)-induced neuronal degeneration in ddY mouse embryo cortical neurons assessed as restoration of axonal outgrowth by measuring length of phosphorylated neurofilament-H-positive neurites at 10 uM treated 3 days post amylo | 2016 | Journal of natural products, 07-22, Volume: 79, Issue:7 | Effects of Oleanane-Type Triterpene Saponins from the Leaves of Eleutherococcus senticosus in an Axonal Outgrowth Assay. |
AID1453375 | Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate preincubated for 15 mins followed by substrate addition by spectrophotometric method | 2017 | Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13 | Potential anti-gout constituents as xanthine oxidase inhibitor from the fruits of Stauntonia brachyanthera. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |